Abstract
This interrupted time series analysis evaluates the association of nudges with zoledronate prescription vs more expensive denosumab.
MeSH terms
-
Aged
-
Bone Density Conservation Agents / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Choice Behavior
-
Denosumab / therapeutic use*
-
Female
-
Humans
-
Lung Neoplasms / drug therapy*
-
Male
-
Medical Oncology
-
Middle Aged
-
Oncologists / psychology*
-
Practice Patterns, Physicians'*
-
Prostatic Neoplasms / drug therapy*
-
Zoledronic Acid / therapeutic use*
Substances
-
Bone Density Conservation Agents
-
Denosumab
-
Zoledronic Acid